3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
223
Pancreatic Neoplasms
140
Stomach Neoplasms
87
Carcinoma, Hepatocellular
82
Carcinoma, Non-Small-Cell Lung
64
Esophageal Neoplasms
63
Colonic Neoplasms
60
Breast Neoplasms
52
Rectal Neoplasms
50
Ovarian Neoplasms
46
Neoplasm Metastasis
41
Lung Neoplasms
41
Cholangiocarcinoma
41
Neoplasms
39
Prostatic Neoplasms
33
Melanoma
33
Liver Neoplasms
33
Gastrointestinal Neoplasms
33
Sarcoma
27
Endometrial Neoplasms
27
Carcinoma, Renal Cell
24
Squamous Cell Carcinoma of Head and Neck
23
Biliary Tract Neoplasms
23
Urinary Bladder Neoplasms
21
Uterine Cervical Neoplasms
19
Esophageal Squamous Cell Carcinoma
19
Head and Neck Neoplasms
16
Adenocarcinoma Of Esophagus
16
Small Cell Lung Carcinoma
15
Gastrointestinal Stromal Tumors
15
Interventions
atezolizumab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatty Liver
×
Gastrointestinal
×
30 days
×
Clear all
NCT06096779
2026-06-01
Kirros
Genentech, Inc.
Phase 2
Recruiting
30 enrolled